Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Barbara Armstead"'
Autor:
A Wein, K.R. Fox, B Zoltick, Rosemarie Mick, S. B. Malkowicz, Barbara Armstead, P Ramchandani, David J. Vaughn, Christopher P. Holroyde
Publikováno v:
Journal of Clinical Oncology. 16:255-260
PURPOSE To determine the toxicity and efficacy of an outpatient regimen of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium. PATIENTS AND METHODS Patients received paclitaxel 150 to 225 mg/m2 over 3 hours followed by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c95709f63255517dc70a115e15c98b
https://doi.org/10.1200/jco.1998.16.1.255
https://doi.org/10.1200/jco.1998.16.1.255
Autor:
David M. Mintzer, Neal J. Meropol, David J. Vaughn, Daniel G. Haller, Barbara Armstead, Christopher P. Holroyde, Isaac F. Nuamah, Harold O. Douglass
Publikováno v:
American Journal of Clinical Oncology. 20:242-246
A Phase II study was performed to evaluate the activity and toxicity of 5-fluorouracil, leucovorin, Adriamycin, and cisplatin combination chemotherapy (FLAP) in patients with previously untreated advanced gastric and gastroesophageal (GE) junction ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e218647d0f12c5cd1febb3ad6fd322
https://doi.org/10.1097/00000421-199706000-00006
https://doi.org/10.1097/00000421-199706000-00006
Autor:
S. B. Malkowicz, David J. Vaughn, Christopher P. Holroyde, Barbara Armstead, Daniel G. Haller, T Peacock, B Zoltick, Steven Stein
Publikováno v:
American journal of clinical oncology. 24(3)
Toremifene has antiestrogenic and estrogenic properties in vitro and in vivo. In addition, it may have antiangiogenesis and antimicrotubule properties at higher doses. Studies have demonstrated the efficacy of this agent in the treatment of metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5e5152773e161e1e6ae6109843c613
https://pubmed.ncbi.nlm.nih.gov/11404501
https://pubmed.ncbi.nlm.nih.gov/11404501
Publikováno v:
American journal of clinical oncology. 23(1)
A phase II study was performed to evaluate the activity and toxicity of 5-fluorouracil (5-FU), leucovorin, and inteferon alpha-2a in metastatic pancreatic carcinoma. Twenty-three patients were entered in this study. Four patients withdrew before rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaaff2c97a848b760c2213f530fbf5f4
https://pubmed.ncbi.nlm.nih.gov/10683073
https://pubmed.ncbi.nlm.nih.gov/10683073
Publikováno v:
American journal of clinical oncology. 19(3)
In a pilot trial, we treated patients with solid tumors with 5-FU (5-fluorouracil), leucovorin (LV), and cisplatin (FLP) with Adriamycin in selected patients (FLAP). 5-FU/LV were administered weekly for 6 weeks, with cisplatin at two dose levels (and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7fc8d293aafbddb3155d9ff141f29f
https://pubmed.ncbi.nlm.nih.gov/8638533
https://pubmed.ncbi.nlm.nih.gov/8638533